Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
GeneDx Holdings Corp.
| Metric | GeneDx Holdings Corp. WGSHealthcare |
|---|---|
| Quality Score | 68 / 100 |
| Revenue (latest) | $428M |
| Net income (latest) | −$21M |
| Operating margin | −3.1% |
| Net margin | −4.9% |
| Return on equity | −6.8% |
| Return on assets | −4.0% |
| Return on capital (ROCE) | −3.2% |
| Debt / equity | 0.70× |
| Revenue growth (YoY) | 40.0% |
| Altman Z″ (distress) | -5.22 |
| Accruals / assets | −10.4% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.